Налтрексон

Quick links

Choose a section

Quick links to important sections

Advertisements

Налтрексон

Advertisements
Advertisements
Advertisements

Overview of Налтрексон

What is Naltrexone?

Naltrexone is a synthetic medication primarily used to support individuals recovering from substance use disorders. Its active compound is Naltrexone Hydrochloride, and it belongs to the pharmacological class of opioid antagonists. This drug is clinically recognized as a vital component of Medication-Assisted Treatment (MAT) and is classified as a non-addictive mono-preparation that works by blocking opioid effects in the body.

Quick Facts about Naltrexone
Active Ingredient Naltrexone Hydrochloride
Pharmacological Class Opioid Antagonist (Pure)
Forms Tablets (Oral), Extended-Release Injection (Intramuscular)
Common Use Support abstinence from opioids and alcohol
Origin Synthetic compound

1. Classification and Composition: The Opioid Antagonist

Naltrexone is classified as a pure opioid antagonist that works by occupying opioid receptors in the brain, particularly the mu-receptor. The compound is synthetic, having been developed as an evolution of early narcotic antagonists. Naltrexone’s core differentiation lies in its status as a non-scheduled, prescription-only (Rx) drug, distinguishing it from controlled substances often used in dependency treatment.


2. Forms and General Goal

Naltrexone is available as oral tablets and as a solution for extended-release intramuscular injection. This medication is approved to prevent relapse to opioid dependence and to treat alcohol dependence. The general goal is achieved by the drug's action: providing a persistent blockade. This blockade is the key factor in reducing psychological and physical cravings and eliminating the rewarding effects of alcohol and opioids, which supports the patient's commitment to recovery.

Advertisements

What side effects are possible with Налтрексон?

Possible Side Effects and Safety Information

The safety profile of Naltrexone is classified according to official regulatory documents, grouping potential effects by frequency and system-organ class. The most frequently documented reactions often involve the Gastrointestinal System and the Nervous System.

Frequency Classification (Based on Regulatory Data)
Very Common (Affects ge 1 in 10): Nausea, headache, insomnia, anxiety/nervousness, abdominal pain, joint pain.
Common (Affects ge 1 in 100): Depression, dizziness, somnolence, vomiting, constipation, decreased appetite.

Serious adverse reactions are specifically noted in official labeling. These include the potential for hepatotoxicity, which is why the medicine is contraindicated in individuals with acute hepatitis or liver failure. There is also a documented risk of increased sensitivity to opioids and potentially fatal opioid overdose following the end of the drug’s blockade effect or treatment cessation. Cases of suicidal ideation and depression have been reported, requiring consideration of the patient’s psychological state. The extended-release form may be associated with severe injection site reactions.

Safety Constraints and Considerations

Administration of Naltrexone requires that the patient be confirmed opioid-free prior to initiation to avoid precipitating an acute withdrawal syndrome. Safety considerations for specific populations are also defined: caution is advised for patients with moderate to severe renal impairment, and the medicine is contraindicated in acute hepatic failure. Official documentation indicates that the safety and effectiveness have not been established in pediatric patients.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation identifies two distinct overdose risks associated with Naltrexone. The first is toxicity from excessive Naltrexone intake, which is documented by hepatocellular injury and abnormal hepatic function test parameters primarily at doses of 300 mg/day or greater. Population-specific notes indicate that obese and elderly patients may show abnormal liver enzyme levels at these higher dosages.


Life-Threatening Risks and Emergency Action

The second, more critical risk involves the potential for life-threatening opioid poisoning and fatal opioid overdose when individuals attempt to overcome the Naltrexone blockade with large doses of exogenous opioids, which may lead to respiratory and circulatory impairment. Attempts to override the blockade may also result in excessive symptoms of histamine release (e.g., generalized erythema).

Immediate medical attention or calling emergency services is mandatory for any suspected opioid overdose/poisoning or for signs of acute liver problems. In the event of an overdose, management is symptomatic and supportive, carried out in a closely supervised environment. Regulatory information confirms that no specific antidote is known for an overdose of Naltrexone itself.

Advertisements

Therapeutic Uses of Налтрексон

What Naltrexone Treats: Main Uses and Benefits

Naltrexone is commonly used to help manage symptoms associated with chronic Substance Use Disorders, including Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD). It is considered relevant in supporting recovery by assisting with core behavioral and psychological symptoms. The medication is applied in settings of Medication-Assisted Treatment (MAT), relevant when additional symptomatic support is needed for abstinence.


Targeting Cravings and Relapse Risk

The medication is applied when managing intense cravings and urges for alcohol or opioids, which may be linked to relapse risk in recovery. It is relevant for easing symptoms that interfere with daily comfort. In clinical scenarios, Naltrexone may assist with reducing the intensity of the substance's effect, which contributes to easing the drive for repeated use. As a supportive measure, it may help patients cope more steadily with these impulses, assisting with day-to-day comfort. Its use may be applied in addressing symptom clusters that include psychological urges and reward perception, offering supportive therapeutic benefit during the post-detoxification phase and in conditions marked by heightened symptoms.

Quick Fact: Support for Cravings and Urges
Naltrexone supports patients by helping to manage the compulsive psychological urges that may interfere with functional stability, and is applied when additional symptomatic support is needed.
Advertisements

Eligibility and Restrictions for Use

The official regulatory criteria for Naltrexone define who is eligible to use the medicine based primarily on current opioid use, liver health, and age.

Contraindications and Restrictions

Category Contraindicated Populations (Must Not Use)
Opioid Status Patients with current physiologic opioid dependence or those in acute opioid withdrawal.
Any individual who has a positive opioid screen or is receiving opioid analgesics.
Organ Function Patients with acute hepatitis or liver failure, and patients with severe renal failure (EMA/HPRA).

Category Restricted or Conditional Use
Age Groups Not recommended for children and adolescents under 18 years, as safety and efficacy have not been established.
Organ Function Caution is recommended in patients with renal or mild-to-moderate hepatic impairment.
Physiological Status Breastfeeding is not advised; use in pregnancy is generally considered only when the potential benefit outweighs the unknown risk (FDA Category C).

Treatment is allowed for adults who are confirmed to be opioid-free for the required duration, typically 7–10 days, prior to initiation.

Advertisements

What should I know about interactions with other medicines?

The most critical aspect of naltrexone's interaction profile involves its function as a pure opioid antagonist. This mechanism creates highly significant constraints on co-administration with other substances.

Opioid Interactions and Restrictions

Naltrexone is contraindicated for use in individuals who are currently physically dependent on opioids, are in acute opioid withdrawal, or are receiving opioid analgesics. This includes prescription pain relievers, cough and cold preparations, and anti-diarrheal medicines that contain opioid derivatives.

  • Risk of Withdrawal: Initiating naltrexone while opioids remain in the body will precipitate a rapid and potentially severe opioid withdrawal syndrome. Patients must be opioid-free for a sufficient period—typically 7 to 10 days for short-acting opioids, and longer for long-acting opioids—before starting treatment.
  • Risk of Overdose: Naltrexone blocks the effects of opioids. Attempting to overcome this blockade by taking large doses of opioids can lead to serious injury, coma, or fatal respiratory depression. Tolerance to opioids is also reduced while on naltrexone and after discontinuing it, making previous doses potentially lethal.

Other Documented Interactions

Caution is advised when co-administering naltrexone with other medications, as formal drug interaction studies have not been performed for most non-opioid substances.

Interacting Product Category Noteworthy Interaction Statement
Disulfiram Use of two potentially liver-damaging medications is not generally recommended unless benefits outweigh the risks.
Thioridazine (Antipsychotic) Concurrent use has been associated with reports of lethargy and somnolence.
Acamprosate Naltrexone may increase the plasma concentration of Acamprosate.
Opioid Antagonists (e.g., Naloxegol) May increase the risk of opioid withdrawal or the effects of either drug.
Advertisements

Mechanism of Action

How Naltrexone Works

Targeted Blockade of mu-Opioid Receptors

Naltrexone functions as a pure competitive antagonist with high affinity for the mathbfmu-Opioid Receptor (MOR), the primary biological target. By occupying the MOR sites, Naltrexone displaces both the body's natural opioid peptides and any exogenous opioid compounds, functionally inactivating the receptor and preventing its normal signal transduction cascade. This targeted binding is the molecular foundation that dictates the drug's physiological influence.

Inhibition of the CNS Reward Circuitry

The molecular blockade translates to a systemic effect on the Mesolimbic Dopaminergic Pathway, the brain's main reward circuit. By preventing opioid receptor activation in these regions, Naltrexone interrupts the release of dopamine that typically mediates positive reinforcement and euphoria. The resulting physiological consequence is the inhibition of opioid-mediated positive reinforcement and the reduction of signaling linked to the rewarding properties of substances.

Specific Mechanism and Physiological Constraints

Naltrexone’s mechanism is highly specific to the opioid receptor system, limiting its biological influence solely to pathways modulated by these receptors. This targeted action results in specific physiological consequences within the CNS, although the competitive nature of the blockade means that high concentrations of ligands can theoretically overwhelm the mechanism.

Advertisements

Dosage and Administration Information

Naltrexone is administered through two official routes: the oral tablet and the extended-release injectable suspension. The method of use is determined by the specific form and its regulatory guidelines, which define dosing, frequency, and administration technique.

Administration Routes and Standardized Dosing

Form and Route Standard Adult Dosing Regimen Frequency and Timing Special Conditions
Oral Tablet (50 mg) 50 mg once daily. For Opioid Use Disorder (OUD) initiation, dosing may begin with 25 mg (half a tablet) on the first day. Once daily. The tablet can generally be taken without regard to food. Tablets should not be crushed or chewed, except when splitting for the initial 25 mg dose.
Extended-Release Injection (380 mg) 380 mg as a single dose. Once every four weeks or once a month. Must be administered as a deep intramuscular injection into the gluteal muscle only, by a healthcare professional.

Official Use Patterns and Procedural Rules

The extended-release injection requires a healthcare professional to reconstitute the powder with the provided diluent immediately before administration. For the oral tablet, alternative regimens, such as 100 mg every other day, may be used in certain settings to support adherence, though 50 mg daily is standard. Treatment is generally intended for continuous use as part of a long-term plan, and no specific dose adjustment is required for older adults based on age alone. If a dose of the monthly injection is missed, it should be administered as soon as feasible, but readministration earlier than four weeks is not recommended.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Naltrexone is an opioid receptor antagonist primarily investigated for its potential role in the management of Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD). Its clinical application is generally studied as an adjunct to psychosocial therapy.

Efficacy Findings

Randomized controlled trials (RCTs) have consistently investigated naltrexone's association with key patient outcomes. Researchers reported that, compared to placebo, naltrexone:

  • AUD: Was associated with reduced rates of heavy drinking and an increased time to a relapse event in individuals with AUD. The effect was observed to be moderate and not uniform across all studied populations.
  • OUD: The extended-release injectable formulation has been associated with higher rates of treatment retention and abstinence compared to placebo or treatment as usual.

Safety and Tolerability

Across multiple studies, the safety and tolerability profile of naltrexone were evaluated. The agent is considered generally well-tolerated when administered appropriately.

The most frequently reported adverse events observed in clinical trials include:

System Common Adverse Events
Gastrointestinal Nausea, vomiting, abdominal cramping
Central Nervous System Headache, dizziness, nervousness

It is essential to note that naltrexone is an opioid antagonist. Its administration to individuals currently using opioids may precipitate acute withdrawal symptoms, which is a significant safety consideration strictly addressed within study protocols. Limited data suggests that individuals with underlying liver issues may require careful monitoring.

Key Studies & References

  1. Opioid antagonists for alcohol dependence (Cochrane Review)
  2. The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis
  3. A Review of Naltrexone Effectiveness for Alcohol Use Disorder Among Women
  4. Extended Release Naltrexone Prevents Opioid Relapse in Criminal Justice Offenders (RCT Summary)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Налтрексон (FAQ)

Q: How quickly does Naltrexone start working for alcohol use?

According to regulatory documents, the oral tablet is generally well absorbed into the body. The therapeutic effect, which is the blocking action of the medicine, typically begins within approximately one hour after taking the dose.


Q: How long do people usually need to stay on Naltrexone treatment?

Treatment with Naltrexone is often intended to be part of a continuous, long-term management program, as described in official use patterns. The overall duration is typically determined on an individual basis, following evaluation by a prescriber.


Q: What are the most commonly reported side effects of Naltrexone?

Official product information classifies the most frequently reported adverse effects as 'Very Common,' meaning they affect ge 1 in 10 patients. These often include symptoms like nausea, headache, insomnia (trouble sleeping), anxiety or nervousness, abdominal pain, and joint pain.


Q: Does Naltrexone affect the liver and is it safe for someone with liver issues?

Regulatory documents contain warnings that Naltrexone can cause hepatocellular injury (damage to the liver) when given in excessive doses. Use is contraindicated (generally not used) in individuals who have acute hepatitis or liver failure.


Q: What kind of pre-treatment tests are usually mentioned in the official prescribing information?

Official prescribing information recommends screening tests to confirm the absence of opioids in the body and indicates the need for baseline and periodic liver function tests to be considered.


Q: Does taking Naltrexone make it harder to treat pain in an emergency?

Yes, because Naltrexone is classified as a powerful opioid antagonist that blocks the effects of pain-relieving opioids. In an emergency, pain may need to be managed with non-opioid medications, or high doses of opioid analgesics may be required under careful medical supervision.


Q: Can Naltrexone be taken with other medicines for mental health conditions?

Formal studies on interactions with most non-opioid medications are limited. Official labeling notes specific caution is advised for co-administration with some psychiatric medicines, such as Thioridazine, due to a potential increase in sleepiness.


Q: How does Naltrexone affect the body's natural pain response?

Naltrexone is a competitive antagonist that works by occupying the body's mu-opioid receptors. By blocking these sites, the medicine prevents the action of external opioid compounds as well as the body's own natural opioid peptides, known as endorphins.


Q: How is the effectiveness of Naltrexone measured in clinical trials?

Effectiveness in clinical studies is typically measured by patient outcomes. For alcohol use, this includes a reduction in heavy drinking days and increased time to relapse. For opioid use, outcomes include higher rates of abstinence and treatment retention.


Q: What is the main difference between Naltrexone and similar addiction medicines?

Naltrexone is classified as a pure opioid antagonist. This means its core function is to physically block the euphoric effects of opioids and alcohol by occupying receptors, which is a different mechanism from other medications used in dependency treatment.


Q: Can Naltrexone cause changes in mood or depression?

Yes. Official documents list depression as a common side effect of Naltrexone. Warnings also note the potential for suicidal ideation (thoughts of self-harm), which is why a patient's mental state is a critical consideration during treatment.


Q: Do you feel 'high' or different after taking Naltrexone?

No. Naltrexone is classified as a non-addictive medication. Its purpose is to block the euphoric and rewarding effects associated with the use of alcohol and opioids, so it does not produce a 'high' or euphoric sensation itself.


Q: Are there any specific foods or drinks to avoid while using Naltrexone?

According to official product information, the oral tablet can generally be taken without regard to food (with or without a meal). The regulatory labeling does not list any specific food groups or common beverages that must be avoided during treatment.


Q: Can older adults or elderly people use Naltrexone?

The medicine is generally approved for use in adults. Official labeling states that no specific dose adjustment is required for older adults based on age alone, but caution is advised for those who may have reduced kidney or liver function.


Q: Is it normal to have trouble sleeping when starting Naltrexone?

Insomnia (difficulty sleeping) is listed in regulatory data as a very common side effect. Like many adverse events, this symptom may be more prominent when a patient first begins treatment with the medication.


Q: Can I take Naltrexone if I am taking over-the-counter pain relievers?

Non-opioid over-the-counter pain relievers, such as Acetaminophen or common NSAIDs, do not interact with the primary blocking action of Naltrexone and are generally considered acceptable. However, any pain reliever containing an opioid is contraindicated.


Q: What happens if I miss a dose of Naltrexone?

Official guidance emphasizes the importance of continuous adherence to treatment. For the oral tablet, if a dose is missed, a patient is advised not to double the next dose.


Q: Does Naltrexone help with cravings, or does it only block effects?

Official documents state that Naltrexone is intended to help with both. It is described as reducing the urge or cravings for alcohol and opioids, and it also functions to block the euphoric and reinforcing effects of those substances.


Q: Is there a recommended time of day to take the Naltrexone tablet?

Official documents state that the oral tablet can generally be taken without regard to food. The manufacturer does not specify a certain time of the day (morning or evening) as being required for dosing.


Q: Is the injectable form of Naltrexone the same as the tablet form?

No. Both contain the active ingredient Naltrexone Hydrochloride, but they are different formulations. The tablet is an immediate-release daily dose, while the injection is an extended-release suspension administered into the muscle once every four weeks.


Q: Does Naltrexone interact with common anxiety or sleep medications?

Formal studies on drug interactions are limited for many non-opioid medications. The official label notes specific caution is advised when using Naltrexone alongside some non-opioid medicines.


Q: Can I drive or operate machinery while taking Naltrexone?

Official warnings note that common side effects can include central nervous system effects such as dizziness and somnolence (sleepiness). Patients should be aware of the possibility of reduced ability to drive or operate complex machinery until they know how the medication affects them.


Q: Is there a risk of becoming dependent on or addicted to Naltrexone?

No. Naltrexone is classified in official documents as a non-addictive medication and is not a controlled substance. It has no abuse potential because its mechanism of action is to block the effects of opioids rather than activate the brain’s reward pathways.


Q: Can Naltrexone interact with blood pressure medications?

Official documents do not list a major, general interaction with most blood pressure medications for Naltrexone alone. Since interaction studies are limited, specific risks should be assessed by a prescriber.


Q: Does Naltrexone require a special prescription or monitoring?

Naltrexone is a prescription-only medicine. Official prescribing information indicates that laboratory monitoring of liver function is generally required, along with a negative opioid test prior to starting treatment.


Q: What age groups are included in the official studies for Naltrexone use?

The safety and effectiveness of Naltrexone for its approved uses have been established primarily through studies in adult patients. It is not recommended for children and adolescents under 18 years of age.


Q: Is the benefit of Naltrexone maintained after stopping the medicine?

Official regulatory information describes Naltrexone as generally intended for continuous use as part of a long-term treatment plan. Regulatory warnings note that tolerance to opioids is reduced after stopping the medication, which increases the risk of serious injury or overdose if opioids are subsequently used.


Q: Does Naltrexone cause tiredness or fatigue?

Yes. Fatigue is listed as a commonly reported adverse event in official documents. Other related central nervous system effects such as somnolence (sleepiness) are also frequently reported.


Q: What is meant by the 'opioid-free interval' before starting treatment?

This term refers to the required minimum period of time that a patient must completely abstain from all opioids (typically 7 to 10 days or longer) prior to starting Naltrexone. This is necessary to prevent precipitating an acute and severe opioid withdrawal syndrome.


Q: Does official information say anything about the long-term effects of Naltrexone on the brain?

Official documents explain that Naltrexone’s action is to block mu-opioid receptors in the brain’s reward circuitry. This mechanism modulates brain activity by interrupting the release of dopamine that is associated with the euphoric and reinforcing effects of substances.


Q: What are the main goals of treatment with Naltrexone described in official sources?

The primary goals of treatment are defined in regulatory documents as preventing relapse to opioid dependence (after detoxification) and treating alcohol dependence. The drug's mechanism supports these goals by reducing cravings and blocking the reinforcing effects.


Q: What are the findings on Naltrexone use in adolescents?

Official regulatory documents state that the safety and effectiveness have not been established in pediatric patients (including adolescents). Therefore, use of the medicine in this population is not recommended.


Q: Are there specific symptoms that require immediate medical attention while on Naltrexone?

Yes. Official warnings identify serious adverse reactions that require prompt medical attention. These include signs of liver damage (e.g., severe stomach pain, dark urine, yellowing of skin/eyes), signs of a severe allergic reaction, or the emergence of suicidal thoughts.


Q: Does Naltrexone have an effect on appetite or body weight?

Official documents list decreased appetite as a common side effect of Naltrexone. However, the effect on body weight is generally not noted in regulatory data as a primary or commonly reported adverse reaction.

Advertisements

How should Налтрексон be stored and disposed of?

Storage and Disposal Requirements

The required storage conditions for naltrexone depend on the formulation, as detailed in official regulatory documents.

Storage Conditions

Formulation Required Temperature Handling Constraints
Oral Tablets Controlled Room Temperature (20 C to 25 C) Store in a tight container; protect from moisture and light.
Injection Refrigerated (2 C to 8 C) Do not freeze; store in the original carton.

The injectable suspension may be stored outside of the refrigerator for a maximum of 7 days at a temperature not exceeding 25 C prior to use. Both forms must be kept out of the sight and reach of children.

Disposal

Unused or expired product must be disposed of according to local regulatory requirements and should not be discarded into household waste or wastewater. Used injectable components, such as needles and syringes, must be placed into a designated, puncture-resistant sharps disposal container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Налтрексон found in:

A-Z Index: